Skip to main content

Oncology Startups

Updated November 2026

Companies in the oncology sector developing innovative solutions and technologies.

Explore 313 recently funded oncology companies with verified founder contact information and fundraising data.

Total Companies
313
Total Funding
$828.4M
Avg Funding
$33.1M
Global Reach
6
countries

Top Cities for Oncology

South San Francisco
Cranford
Brno
Geneva
Newton
Minneapolis

Recently Funded Companies

Export
South San Francisco, United States

Cartography is an oncology company that develops cancer immunotherapies that target novel and highly specific tumor antigens.

May 2026

Founder Contacts

41,000+ verified contacts

Cranford, United States

Citius Oncology is a pharmaceutical company that provides the development and commercialization of innovative oncology therapies.

$25.0M raised
May 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

$550K raised
May 2026

Founder Contacts

41,000+ verified contacts

Brno, Czech Republic

Casinvent Pharma develops therapeutic options for the treatment of selected malignancies.

Apr 2026

Founder Contacts

41,000+ verified contacts

South San Francisco, United States

Allogene Therapeutics is a biotechnology company catalyzing cancer treatment through the development of CAR T therapy.

$200.4M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Geneva, Switzerland

Geneva-based MedTech spin-off from CERN, specializing in the development and manufacturing of innovative nuclear imaging systems.

$2.6M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Newton, United States

TransCode Therapeutics is an RNA oncology company that develops and commercializes drugs for the treatment of metastatic cancer.

$6.0M raised
Apr 2026

Founder Contacts

41,000+ verified contacts

Minneapolis, United States

Sub-Q Bionics is a medtech company, that aids the management of chronic pain and debilitating symptoms of lymphedema specially for women.

$1.5M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Foster City, United States

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

$2.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Groton, United States

NeoSoma is a neuro-oncology AI platform providing AI imaging solutions for precise medical management.

$3.5M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Vor Biopharma is an immuno-oncology company that develops therapies for treating cancer.

$75.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Bozeman, United States

ALERCELL AI-powered epigenetic diagnostic platform detecting leukemia up to 41 months before clinical symptoms.

Mar 2026

Founder Contacts

41,000+ verified contacts

Barcelona, Spain

Peptomyc focuses on the development of a new generation of cell-penetrating peptides targeting the Myconcoprotein for cancer treatment.

$5.8M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Crossbow Therapeutics is a biotech company that develops targeted therapies to address cancer antigens.

$77.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Berwyn, United States

Persevere Therapeutics is a clinical-stage pharmaceutical company that develops novel therapeutics for effective cancer treatments.

$1.6M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Chicago, United States

MAIA Biotechnology is a clinical-stage biopharmaceutical company developing cancer therapies that target telomeres through immunotherapy.

$30.0M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Paris, France

Egle Therapeutics is a biotechnology company focused on developing immunotherapies for oncology and autoimmune diseases.

$9.4M raised
Mar 2026

Founder Contacts

41,000+ verified contacts

Cambridge, United States

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

$150.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Washington, United States

CancerNavigator offers cancer navigation and analytics, connecting patients with care experts and providing personalized support.

$7.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Redwood City, United States

Coherus Biosciences develops, manufactures, and commercializes biologic therapeutics for oncology and inflammatory diseases.

$50.1M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Nashville, United States

Atlas Oncology Partners operates a value-based oncology enablement platform supporting community oncology practices.

$28.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Waltham, United States

Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.

$40.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Boston, United States

Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.

$52.0M raised
Feb 2026

Founder Contacts

41,000+ verified contacts

Phoenix, United States

Breakthru Medicine develops novel therapeutic modalities aimed at treating cancer by targeting hard-to-drug disease mechanisms.

$60.0M raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Calgary, Canada

Onco-Innovations is a biotech business that develops and commercializes medicines for various cancers.

$886K raised
Jan 2026

Founder Contacts

41,000+ verified contacts

Showing 51 to 75 of 313 companies

About the Oncology Startup Ecosystem

The oncology sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Oncology

Oncology companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The oncology sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Oncology Funding Breakdown

Here is how funding is distributed among the 313 oncology companies tracked in the VCBacked database.

Average Funding
$33.1M
Total Funding Tracked
$828.4M
Countries Represented
6

Distribution by Funding Stage

Other25 companies

Top Cities for Oncology

1.South San Francisco
3 companies$200.9M
2.Cambridge
3 companies$302.0M
3.Cranford
1 companies$25.0M
4.Brno
1 companiesUndisclosed
5.Geneva
1 companies$2.6M

Related Industries

Companies in the oncology sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Oncology Startups?

Perfect for: B2B sales teams targeting oncology companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

313 Oncology Startups (2026) — Recently Funded — Page 3 | VCBacked